Centenaire Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 3

Centenaire General Information

Description

Developer of antibody therapies designed to treat cancer and immune diseases in patients. The company's therapies focus on developing an antibody platform based on proprietary technology to develop cancer-targeted drugs, enabling medical professionals to easily cure cancer without any surgery.

Contact Information

Website
www.ctnbio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Number 803 11, Geumto-ro 80beon-gil
  • Sujeong-gu
  • Seongnam, Gyeonggi 13453
  • South Korea
+82
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Drug Discovery
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Number 803 11, Geumto-ro 80beon-gil
  • Sujeong-gu
  • Seongnam, Gyeonggi 13453
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Centenaire Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator Completed Generating Revenue
2. Early Stage VC (Series B) 07-Feb-2023 Completed Startup
1. Early Stage VC (Series A) 22-Mar-2022 $16.4M $16.4M Completed Startup
To view Centenaire’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Centenaire Patents

  • 13

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 9

    Pending

  • Expiring in next 12 mo

Centenaire Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024219897-A1 Antigen-binding protein comprising two fab domains and two fc domains, and use thereof Inactive 21-Apr-2023
JP-2026514684-A Antigen-binding protein containing two fc domains and its use Pending 21-Apr-2023
EP-4700047-A1 Antigen-binding protein containing two fc domains and use thereof Pending 21-Apr-2023
EP-4700047-A4 Antigen-binding protein containing two fc domains and use thereof Pending 21-Apr-2023
WO-2024219894-A1 Antigen-binding protein containing two fc domains and use thereof Inactive 21-Apr-2023 C07K16/461
To view Centenaire’s complete patent history, request access »

Centenaire Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Centenaire Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
BIONOTE Corporation Minority
SDB Investment Venture Capital Minority
Seoul Biohub Accelerator/Incubator
To view Centenaire’s complete investors history, request access »

Ready to get started?

Request a free trial

Centenaire FAQs

  • When was Centenaire founded?

    Centenaire was founded in 2021.

  • Where is Centenaire headquartered?

    Centenaire is headquartered in Seongnam, South Korea.

  • What is the size of Centenaire?

    Centenaire has 21 total employees.

  • What industry is Centenaire in?

    Centenaire’s primary industry is Discovery Tools (Healthcare).

  • Is Centenaire a private or public company?

    Centenaire is a Private company.

  • What is Centenaire’s current revenue?

    The current revenue for Centenaire is .

  • How much funding has Centenaire raised over time?

    Centenaire has raised $16.4M.

  • Who are Centenaire’s investors?

    BIONOTE, SDB Investment, and Seoul Biohub have invested in Centenaire.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process